Pembrolizumab plus chemotherapy in advanced endometrial cancer: a cost-effectiveness analysis by Xinqiang Zhao, Longjiang She, Xiaoning Liu, Zhenggang Bi

Get full text

Cost-effectiveness analysis of sintilimab additional to chemoradiotherapy in high-risk locoregionally advanced nasopharyngeal carcinoma by Longjiang She, Longjiang She, Siqi Tang, Siqi Tang, Jiaqi Han, Jiaqi Han, Guichao Liu, Guichao Liu, Lusi Chen, Lusi Chen, Yang Zhang, Yang Zhang, Weijun Luo, Weijun Luo, Weihan Zuo, Weihan Zuo, Feng Ma, Feng Ma, Yan Xiong, Yan Xiong, Ning Zhang, Ning Zhang

Get full text